1616373-16-0

Basic information

• Product Name: methyl 2-(3-(benzyloxy)-3'-(3-(1-(4-(tert-butyl)benzyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)propyl)-[1,1'-biphenyl]-4-yl)acetate
• Synonyms: methyl 2-(3-(benzyloxy)-3'-(3-(1-(4-(tert-butyl)benzyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)propyl)-[1,1'-biphenyl]-4-yl)acetate
• CAS NO: 1616373-16-0
• Molecular Weight: 631.815
• Mol File: 1616373-16-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 2-(3-(benzyloxy)-3'-(3-(1-(4-(tert-butyl)benzyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)propyl)-[1,1'-biphenyl]-4-yl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-(3-(benzyloxy)-3'-(3-(1-(4-(tert-butyl)benzyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)propyl)-[1,1'-biphenyl]-4-yl)acetate(1616373-16-0)
• EPA Substance Registry System: methyl 2-(3-(benzyloxy)-3'-(3-(1-(4-(tert-butyl)benzyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)propyl)-[1,1'-biphenyl]-4-yl)acetate(1616373-16-0)

Safety Data

• Hazardous Substances Data: 1616373-16-0(Hazardous Substances Data)

Upstream product

• 884504-63-6 4-(3-bromophenyl)-4-oxobutanenitrile 
• 3132-99-8 m-bromobenzoic aldehyde 
• 1616372-71-4 3-(3-(3-bromophenyl)propyl)-1-(4-(tert-butyl)benzyl)-4-ethyl-1H-1,2,4-triazol-5(4H)-one 
• 1616372-69-0 3-(3-(3-bromophenyl)propyl)-4-ethyl-1H-1,2,4-triazol-5(4H)-one 
• 1616372-70-3 2-(4-(3-bromophenyl)butanoyl)-N-ethylhydrazinecarboxamide 
• 860000-78-8 methyl 2-(benzyloxy)-5-bromobenzoate 
• 1616372-72-5 1-(4-(tert-butyl)benzyl)-4-ethyl-3-(3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propyl)-1H-1,2,4-triazol-5(4H)-one 
• 1596464-90-2 4-(3-bromophenyl)butanehydrazide 
• 899350-32-4 4-(3-bromophenyl)-butyric acid 

Downstream Products

• 1616373-17-1 methyl 2-(3'-(3-(1-(4-(tert-butyl)benzyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)propyl)-3-hydroxy-[1,1'-biphenyl]-4-yl)acetate 

Relevant articles and documents

TRIAZOLONE COMPOUNDS AND USES THEREOF

The invention disclosed herein is directed to compounds of Formula I [Formula should be inserted here] and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leuke